Patent · US Active

Physically and chemically stable oral suspensions of givinostat

US10688047B2 · kind B2 · utility

0Cited by
3References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2016
Grant dateJun 23, 2020
Priority date
Expiry dateOct 28, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Physically and chemically stable oral liquid formulations of Givinostat (Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride) are disclosed, together with methods for the preparation thereof. Such oral formulations are in the form of aqueous suspensions and contain Givinostat and/or pharmaceutically acceptable salts and/or derivatives thereof, at least a wetting agent and/or at least a density-imparting agent. Such formulations are suitable for oral administration for systemic therapeutic action.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.